Withing general surgery, the teaching methods will deal with treating complex surgical patients (metabolic and hormonal alteration in the surgical sepsis; nutritional support for critical surgical patients; epidemology and analysis of risk factors for hepatic and renal failure; infections in surgical patients); surgical treatment of obesity (gastroplasty, gastric banding, gastric bypass: physiological alteration of gastric secretion and esophageal motility in the various techniques used for treating obesity; checking the ponderal loss in the various techniques, in particular in relationship with the BMI and adipose cells in the patient; histologic alterations in the esophageal, gastric and duodenal mucous after gsatric procedures); laparoscopic surgery (laparoscopic feasibility in treating hepatobiliary-pancreatic illnesses; study of the advantages and limitations of applying laparoscopy to hepatic-biliary-pancreatic surgery). In the field of malformative paediatric surgery: short gut syndrome in paediatric age and its repercusssions on the developing age; preventive treatment in secondary cryptorchidism and varicocele male sterility. In the field of vascular surgery: evaluation of traditional surgical and endovascular approaches in treating vascular disorders; evaluation of methods to prevent precocious intraoperative embolism during traditional surgery and endovascular treatment; evaluation of the comparative results of traditional surgery and endovascular treatment; study into the possibility of using stem cells in diabetic arteriopathy. In the pancreatic field: epidemological study of acute and chronic pancreatitis; etiopathogenesis of chronic pancreatitis, with special focus on auto-immune and genetic genesis; diagnostics of acute and chronic pancreatitis; diagnosis and surgical and oncological treatment of pancreatic tumours. The research methods will involve the techniques of histology, immune-histochemistry and molecular biology. In the hepatic field: clinic and treatment of chronic viral hepatitis (clinical aspects: evaluation of the clinic development of compensated cirrhosis associated with virus B infection (HBsAg positive) and with virus C (anti-HVC positive), in particular the incidence of complications and liver tumour and the survival level in Europe; evaluation of the role of various genotypes of virus C on the clinical development of chronic liver disease caused by virus C, likewise other prognostic factors, including the role of previous infection from hepatitis B virus; treatment aspects: evaluation of the long-term effectiveness of anti-viral treatment using IFN-alfa in chronic virus B and C liver diseases, with special focus on objectives of clinical importance, such as the prevention of complications developing (hepatic decomposure and liver tumour) and the increased survival level; evaluation of the effectiveness of treatment with a combination of IFN-alfa and ribavirin, an anti-viral drug, in patients with chronic virus C hepatitis who relapse or who do not respond to treatment cycles with IFN-alfa; surgical and oncological treament of liver tumour).
Title "Information for the students".